Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Western medicine diagnosis: meets the COVID-19 diagnosis criteria for confirmed patients, and Chinese medicine diagnosis: meets the New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Seventh Edition) Epidemic diagnosis criteria; 2. 18 to 75 years old, meet the common diagnostic criteria of COVID -19 Inpatients; 3. With cough symptoms.
Exclusion criteria
Exclusion criteria: 1) Primary immunodeficiency, acquired immunodeficiency syndrome, congenital respiratory malformation, congenital heart disease, gastroesophageal reflux disease, lung dysplasia and other basic diseases, with clear evidence of bacterial infection; 2) Having the following conditions Subjects: Asthma requiring daily treatment, any other chronic respiratory diseases and bacterial infections of the respiratory system such as purulent tonsillitis, acute bronchitis, sinusitis, otitis media, etc., other respiratory diseases affecting clinical trial evaluation, chest CT Confirmed that there are basic lung diseases such as severe pulmonary interstitial lesions and bronchiectasis; 3) According to the diagnostic criteria of the "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Seventh Edition)" [3] Diagnosed as severe and critical COVID-19; 4) Pregnant or breastfeeding women; 5) May be transferred to non-COVID-19 designated hospitals within 72 hours; 6) Allergies, such as a history of allergies to 2 or more drugs or food, or known allergies to the ingredients of this drug; 7) The investigator believes that there are any factors that are not suitable for inclusion in the group or that affect the evaluation of the curative effect of the subjects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CT Imaging;SARS-CoV-2-qRT-PCR; | — |
Countries
China
Contacts
Beijing University of Chinese Medicine